Ocular adverse Events of cenegermin Used in neurotrophic Keratopathy: An Analysis of the FDA adverse event reporting system Database

CONCLUSION: This study revealed new cenegermin-related ocular AE signals. Clinical practice requires close monitoring to early identify and manage adverse reactions that may cause occurrence of serious irreversible consequences.PMID:37608598 | DOI:10.1080/14740338.2023.2251389
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Authors: Source Type: research